Cadrenal Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CVKD, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
4
Funds holding
$6714
Total value held
Buying
3 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $3714 | 1112 | +1112 | NEW BUY |
| 2 | Morgan Stanley | $2358 | 706 | +606 | +606.00% |
| 3 | Wells Fargo & Company/Mn | $331 | 99 | — | Held |
| 4 | Barclays Plc | $311 | 93 | +93 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.